Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CHOKSILA.BOthis companyChoksi Laboratories Limited	₹198.90	36.74×	2.82×	1.56×	8.6×	-5.7%	25.2%	11.4%	4.2%	7.7%	5.2%	-3.8%	1.34×	2.75×	1.87×	0.82×	0.0%	4	—	2	C+
ASPIRA.BOAspira Pathlab & Diagnostics Limited	₹126.95	1,117×	4.68×	2.29×	40.57×	-50.8%	35.3%	-0.3%	0.2%	0.4%	-0.5%	1.9%	0.27×	1.41×	-0.19×	1.43×	0.0%	2	—	1	C-
DLCL.BODr. Lalchandani Labs Ltd.	₹6.47	93.8×	0.43×	1.46×	5.92×	658.4%	59.7%	-11.9%	1.5%	0.4%	-2.0%	-17.9%	0.15×	-3.04×	-28.75×	3.79×	0.0%	3	1.33	2	B-
LALPATHLAB.NSDr. Lal PathLabs Limited	₹2,016.50	43.39×	8.73×	7.93×	25.61×	4.3%	42.0%	22.5%	18.3%	20.1%	16.9%	2.4%	0.08×	-0.05×	27.22×	3.48×	1.0%	4	—	2	C+
NIDAN.NSNidan Laboratories & Healthcare Ltd.	₹13.35	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
SAMSRITA.BOSamsrita Labs Ltd.	₹11.74	-3.97×	2.76×	1,792.09×	-3.73×	-99.8%	-2159.7%	-48163.0%	-45085.6%	-69.4%	-64.5%	-15.5%	0.14×	-0×	0×	1×	0.0%	2	—	1	C-
Peer median	—	68.59×	3.72×	5.11×	15.76×	-23.3%	38.6%	-6.1%	0.9%	0.4%	-1.2%	-6.8%	0.14×	-0.03×	-0.1×	2.46×	0.0%	3	1.33	2	—